-
Identification of Predictive Drug Response Signatures and Novel Resistance Genes by Whole Genome Profiling of Lung Tumors
Read MoreLung cancer causes more than a quarter of cancer deaths in Canada, with five-year survival rates among the lowest for commonly diagnosed…
-
Identification of predictive drug response signatures by whole genome profiling of lung tumors
Read MoreNon-small cell lung cancer (NSCLC) accounts for an estimated 80% of known lung cancer cases. In many instances, these tumors are inoperable…